Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.

Tafreshi NK, Silva A, Estrella VC, McCardle TW, Chen T, Jeune-Smith Y, Lloyd MC, Enkemann SA, Smalley KS, Sondak VK, Vagner J, Morse DL.

Mol Pharm. 2013 Aug 5;10(8):3175-85. doi: 10.1021/mp400222j. Epub 2013 Jul 8.

2.

Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance.

Hopewell EL, Zhao W, Fulp WJ, Bronk CC, Lopez AS, Massengill M, Antonia S, Celis E, Haura EB, Enkemann SA, Chen DT, Beg AA.

J Clin Invest. 2013 Jun;123(6):2509-22. doi: 10.1172/JCI67250. Epub 2013 May 1.

3.

Transcriptional response of the sulfur chemolithoautotroph Thiomicrospira crunogena to dissolved inorganic carbon limitation.

Dobrinski KP, Enkemann SA, Yoder SJ, Haller E, Scott KM.

J Bacteriol. 2012 Apr;194(8):2074-81. doi: 10.1128/JB.06504-11. Epub 2012 Feb 10.

4.

Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes.

Tafreshi NK, Bui MM, Bishop K, Lloyd MC, Enkemann SA, Lopez AS, Abrahams D, Carter BW, Vagner J, Grobmyer SR, Gillies RJ, Morse DL.

Clin Cancer Res. 2012 Jan 1;18(1):207-19. doi: 10.1158/1078-0432.CCR-11-0238. Epub 2011 Oct 20. Erratum in: Clin Cancer Res. 2012 Mar 1;18(5):1483. Gobmyer, Stephen R [corrected to Grobmyer, Stephen R].

5.

Upregulation of Fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancer.

Kao WH, Riker AI, Kushwaha DS, Ng K, Enkemann SA, Jove R, Buettner R, Zinn PO, Sánchez NP, Villa JL, D'Andrea AD, Sánchez JL, Kennedy RD, Chen CC, Matta JL.

J Invest Dermatol. 2011 Oct;131(10):2139-42. doi: 10.1038/jid.2011.181. Epub 2011 Jun 23. No abstract available.

6.

A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes.

Tafreshi NK, Enkemann SA, Bui MM, Lloyd MC, Abrahams D, Huynh AS, Kim J, Grobmyer SR, Carter WB, Vagner J, Gillies RJ, Morse DL.

Cancer Res. 2011 Feb 1;71(3):1050-9. doi: 10.1158/0008-5472.CAN-10-3091. Epub 2010 Dec 17.

7.

Standards affecting the consistency of gene expression arrays in clinical applications.

Enkemann SA.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1000-3. doi: 10.1158/1055-9965.EPI-10-0044. Epub 2010 Mar 23. Review.

8.

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.

Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, Shepherd FA, Ding K, Seymour L, Naoki K, Pennell N, Weir B, Verhaak R, Ladd-Acosta C, Golub T, Gruidl M, Sharma A, Szoke J, Zakowski M, Rusch V, Kris M, Viale A, Motoi N, Travis W, Conley B, Seshan VE, Meyerson M, Kuick R, Dobbin KK, Lively T, Jacobson JW, Beer DG.

Nat Med. 2008 Aug;14(8):822-7. doi: 10.1038/nm.1790. Epub 2008 Jul 20.

9.

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J.

BMC Med Genomics. 2008 Apr 28;1:13. doi: 10.1186/1755-8794-1-13.

11.

Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis.

Zhang X, Li P, Bao J, Nicosia SV, Wang H, Enkemann SA, Bai W.

J Biol Chem. 2005 Oct 21;280(42):35458-68. Epub 2005 Aug 10.

12.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk